Seattle Genetics Announces Interim Safety Analysis Supports Continuation Of Lintuzumab Phase IIb Clinical Trial Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that an Independent Data Monitoring Committee (IDMC) has completed a pre-specified safety review of data from the ongoing phase IIb trial of lintuzumab (SGN-33) in combination with low-dose cytarabine chemotherapy for older patients with acute myeloid leukemia (AML).
Source: www.medicalnewstoday.comIn Living Animals, Novel Technique For Fluorescence Tomography Of Tumors Fluorescent molecules - i.e. substances which can be stimulated to emit light - are extremely valuable tools in biological research and medical diagnosis. Fluorescence can be used for instance to analyze the regulation and expression of genes, to locate proteins in cells and tissues, to follow metabolic pathways and to study the location and migration of cells.
Source: www.medicalnewstoday.comCLSI Publishes Guideline For Abbreviated Identification Of Bacteria And Yeast Clinical and Laboratory Standards Institute (CLSI) has recently published an updated document, Abbreviated Identification of Bacteria and Yeast; Approved Guideline-Second Edition (M35-A2) , which includes instructions and flowcharts outlining the minimal characteristics required to identify a limited number of organisms commonly isolated from patient specimens.
Source: www.medicalnewstoday.comAnti-Inflammatory Drugs With Fewer Side Effects Than Aspirin In the treatment of pain, inflammation and fever, non-steroid anti-rheumatic
drugs (NSAR) such as acetylsalicylic acid - more commonly known as Aspirin - or Ibuprofen have always been popular choices. However, had they been tested using today's stringent criteria, many of these
drugs would not have passed the clinical trial stage, due to the potential risks and side effects they entail.
Source: www.medicalnewstoday.comUnder-Reported Dementia Deaths: Hebrew SeniorLife Study Questions Accuracy Of Mortality Statistics Deaths due to dementia and Alzheimer's disease are underreported on death certificates, according to a study conducted by Hebrew SeniorLife's Institute for Aging Research (IFAR), raising concerns about the accuracy of mortality statistics based on these documents.
Source: www.medicalnewstoday.comGuided Therapeutics, Inc. Submits First Module Of Premarket Approval Application For Painless Cervical Cancer Detection To FDA Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced it submitted the first of three modules of its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the LightTouchTM non-invasive cervical cancer detection device.
Source: www.medicalnewstoday.comLow Carb Diet Is Bad For Thinking And Memory A new study from scientists in the US found that when women went on low or zero-carb diets they performed worse on thinking and memory tests compared to reducing calories without reducing carbohydrates. When they put carbs back into their diet, their thinking and memory skills went back to normal.
Source: www.medicalnewstoday.comProbing The Prevalence Of Disordered Eating Behaviors In Diabetics Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame. "Diabetes treatment prescribes obsessive food behavior, such as carbohydrate restriction," said Dr. Deborah Young-Hyman, pediatric psychologist in the Medical College of Georgia's Georgia Prevention Institute.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
